IRC
CRL icon

Investors Research Corp’s Charles River Laboratories CRL Stock Holding History

Investors Research Corp’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8
Closed -$1.81K – 801
2026
Q2 		$1.81K Hold
8
– – ﹤0.01% 695
2026
Q1 		$1.38K Buy
+8
New +$1.48K ﹤0.01% 740

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Investors Research Corp's CRL Position: Q3 2026 in Review

Investors Research Corp sold out of Charles River Laboratories (CRL) in Q3 2026, closing a stake of 8 shares — an estimated $1.81K sold.

Investors Research Corp first reported a position in CRL in Q1 2026 and held it in 2 quarters. The position peaked at $1.81K in Q2 2026. 15 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Investors Research Corp reported no remaining Charles River Laboratories position as of Q3 2026 after selling out during the quarter.
  • Investors Research Corp sold 8 Charles River Laboratories shares in Q3 2026, an estimated $1.81K.
  • Investors Research Corp first reported a position in Charles River Laboratories in Q1 2026 and held it in 2 quarters.
  • Investors Research Corp's Charles River Laboratories position peaked at $1.81K in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.